What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2024-08-14 compared with 2024-05-17 · 75 added, 30 removed, 130 unchanged (45% of the section changed)

18 unchanged sentences

Co-Development Agreement with Rgene dated May 26, 2017 (13)

Lind Letter Agreement dated May 22, 2024 (52)

Lind Form of Warrant dated May 22, 2024 (52)

Business Loan Agreement entered by and between Cathay Bank and American BriVision (Holding) Corporation (16)

60 unchanged sentences

Definitive License Agreement between the Company and ForSeeCon Eye Corporation (49)

Definitive License Agreement between BIOFIRST CORPORATION and ForSeeCon Eye Corporation (49)

Definitive License Agreement between BioFirst Corporationand ForSeeCon

Eye Corporation (49)

Form of Amendment (50)

Definitive License Agreement between the Company and OncoX BioPharma, Inc.

May 23, 2024 (53)

Definitive License Agreement between Biolite, Inc.

and OncoX BioPharma, Inc.

dated May 23, 2024 (53)

Amendment to the Definitive License Agreement between the Company and ForSeeCon Eye Corporation (54)

Amendment to the Definitive License Agreement between BioFirst Corporation

and ForSeeCon Eye Corporation (54)

Amendment to the License Agreement between the Company and AiBtl BioPharma Inc.

Amendment to the License Agreement between BioLite, Inc.

and AiBtl BioPharma Inc.

Certifications pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.+

10 unchanged sentences

Inline XBRL Taxonomy Extension Presentation Linkbase Document.+

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Cover Page Interactive Data File (formatted as Inline XBRL and contained

in Exhibit 101).

* In accordance with SEC Release

1 unchanged sentence

+ Filed herewith

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 16, 2016.

Incorporated by reference to Exhibit 3.01 to the Company’s Form SB-2 filed on June 28, 2002

Incorporated by reference to Exhibit 3.02 to the Company’s Form SB-2, filed on June 28, 2002

Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on March 28, 2016.

Incorporated by reference to Exhibit 3.4 to the Company’s Form S-1, filed on September 13, 2016.

Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K, filed on April 7, 2020

Incorporated by reference to Exhibit 4.1 the Company’s Current Report on Form 8-K, filed on April 24, 2020

Incorporated by reference to Exhibit 10.2 the Company’s Current Report on Form 8-K, filed on February 16, 2016.

Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed on June 9, 2016.

Incorporated by reference to Exhibit 10.3 to the Company’s Annual Report on Form 10-K, filed on January 12, 2017.

Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed on February 22, 2017.

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on July 24, 2017.

Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed on May 30, 2017.

Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed on September 20, 2017.

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on April 24, 2020.

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed April 14, 2020.

Incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed May 15, 2020.

Incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed May 15, 2020

Incorporated by reference to Exhibit 14.1 to the Company’s Amendment No.1 to Form S-1, filed on November 14, 2016.

Incorporated by reference to 21.1 to the Company’s Form S-1, filed on September 13, 2016.

(1) Incorporated by reference to Exhibit

10.1 to the Company’s Current Report on Form 8-K, filed on February 16, 2016.

(2) Incorporated by reference to Exhibit

3.01 to the Company’s Form SB-2 filed on June 28, 2002

(3) Incorporated by reference to Exhibit

3.02 to the Company’s Form SB-2, filed on June 28, 2002

(4) Incorporated by reference to Exhibit

4.1 to the Company’s Current Report on Form 8-K, filed on March 28, 2016.

(5) Incorporated by reference to Exhibit

3.4 to the Company’s Form S-1, filed on September 13, 2016.

(6) Incorporated by reference to Exhibit

3.1 to the Company’s Form 8-K, filed on April 7, 2020

(7) Incorporated by reference to Exhibit

4.1 the Company’s Current Report on Form 8-K, filed on April 24, 2020

(8) Incorporated by reference to Exhibit

10.2 the Company’s Current Report on Form 8-K, filed on February 16, 2016.

(9) Incorporated by reference to

Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed on June 9, 2016.

(10) Incorporated by reference to Exhibit

10.3 to the Company’s Annual Report on Form 10-K, filed on January 12, 2017.

(11) Incorporated by reference to Exhibit

99.1 to the Company’s Current Report on Form 8-K, filed on February 22, 2017.

(12) Incorporated by reference to Exhibit

10.1 to the Company’s Current Report on Form 8-K, filed on July 24, 2017.

(13) Incorporated by reference to Exhibit

99.1 to the Company’s Current Report on Form 8-K, filed on May 30, 2017.

(14) Reserved.

(15) Incorporated by reference to Exhibit

10.3 to the Company’s Current Report on Form 8-K, filed on September 20, 2017.

(16) Incorporated by reference to Exhibit

10.1 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

(17) Incorporated by reference to Exhibit

10.2 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

(18) Incorporated by reference to Exhibit

10.3 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.

(19) Incorporated by reference to Exhibit

10.2 to the Company’s Current Report on Form 8-K, filed on April 24, 2020.

(20) Incorporated by reference to Exhibit

10.1 to the Company’s Current Report on Form 8-K, filed April 14, 2020.

(21) Incorporated by reference to Exhibit

10.15 to the Company’s Annual Report on Form 10-K, filed May 15, 2020.

(22) Incorporated by reference to Exhibit

10.16 to the Company’s Annual Report on Form 10-K, filed May 15, 2020

(23) Incorporated by reference to Exhibit

14.1 to the Company’s Amendment No.1 to Form S-1, filed on November 14, 2016.

(24) Incorporated by reference to 21.1

to the Company’s Form S-1, filed on September 13, 2016.

Incorporated by reference to Exhibit 10.9 to the Company’s Annual Report on Form 10-K, filed May 15, 2020.

2 unchanged sentences

Incorporated by reference to the Current Report on Form 8-K filed on June 8, 2021.

Incorporated by reference to the Quarterly Report on Form 10-Q filed on May 10, 2021.

(29) Incorporated by reference to the

Quarterly Report on Form 10-Q filed on May 10, 2021.

Incorporated by reference to the Current Report on Form 8-K filed on October 8, 2021.

10 unchanged sentences

Incorporated by reference to the Company’s Current Report on Form 8-K/A, filed on January 17, 2024.

Incorporated by reference to the Company’s Current Report on

Form 8-K/A, filed on February 29, 2024.

Incorporated by reference to the Company’s Current Report on Form 8-K/A, filed on February 29, 2024.

Incorporated by reference to the Company’s Annual Report on Form 10-K/A, filed on June 6, 2022

6 unchanged sentences

Incorporated by reference to the Company’s Current Report on Form 8-K, filed on May 9, 2024

Incorporated by reference to the Company’s Current Report on Form 8-K, filed on May 23, 2024

Incorporated by reference to the Company’s Current Report on Form 8-K, filed on May 24, 2024

Incorporated by reference to the Company’s Current Report on Form 8-K, filed on June 24, 2024

Incorporated by reference to the Company’s Current Report on Form 8-K, filed on June 25, 2024

Pursuant to the requirements of the Securities

1 unchanged sentence

ABVC BioPharma, Inc.

August 14, 2024

/s/ Uttam Patil

2 unchanged sentences

ABVC BioPharma, Inc.

/s/ Leeds Chow

Chief Financial Officer

August 14, 2024

/s/ Uttam Patil

Interim Chief Financial Officer

(Principal Financial Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information